VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly Study to assess safety and immunogenicity in high-priority, at-risk population; top-line results expected in second quarter of 2015 CRANBURY, NJ,...
CardioKinetix Completes $50 Million Financing and Signs Agreement with Edwards Lifesciences, Including Exclusive Option to Purchase Menlo Park, Calif. — December 9, 2014 — CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart...
IlluminOss Medical Caps off Flagship Year with Addition of New Patents to Bone Fixation Portfolio 2014 Marked by Continued Success in International Orthopedics Markets and Conditional Clearance for First U.S. Clinical Trial to Begin in 2015 East Providence, RI...
Relypsa Announces FDA Acceptance of New Drug Application for Patiromer for Oral Suspension to Treat Hyperkalemia REDWOOD CITY, Calif., Dec. 15, 2014 (GLOBE NEWSWIRE) — Relypsa, Inc. (Nasdaq:RLYP), today announced that the U.S. Food and Drug Administration (FDA)...
Karyopharm Announces Addition to the NASDAQ Biotechnology Index NEWTON, Mass., Dec. 15, 2014 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced today that it has been selected for addition to...
Recent Comments